Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 40001-40050 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06748248
Suspension Therapy Effects on Mobility and Balance in Down Syndrome
NA
Recruiting
26 participants
Started: Sep 24, 2024 · Completed: Jan 15, 2025
1 condition
1 sponsor
2 locations
NCT06776861
A Prospective, Multicenter, Observational Cohort Study Assessing the Efficacy and Safety of Radiotherapy-sensitized Immunotherapy in Advanced Breast Cancer
N/A
Recruiting
150 participants
Started: Sep 24, 2024 · Completed: Sep 10, 2028
1 condition
1 sponsor
1 location
NCT06775275
A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC
PHASE2
Recruiting
60 participants
Started: Sep 24, 2024 · Completed: Dec 31, 2029
1 condition
1 sponsor
1 location
NCT06504446
Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough
PHASE2
Recruiting
455 participants
Started: Sep 24, 2024 · Completed: Nov 10, 2025
1 condition
2 sponsors
102 locations
NCT07115134
Efficacy of a Novel Prototype Gastrostomy Tube Anchor Dressing
NA
Recruiting
75 participants
Started: Sep 24, 2024 · Completed: Dec 18, 2027
2 conditions
1 sponsor
1 location
NCT06686784
Using a Mentoring Afterschool Program to Improve Adolescent Mental Health and Physical Activity: A Pilot Study
NA
Active, not recruiting
209 participants
Started: Sep 24, 2024 · Completed: Apr 15, 2026
1 condition
1 sponsor
1 location
NCT06592794
A Study to Investigate the Safety and Efficacy of mRNA-1403 in Participants ≥18 Years of Age for the Prevention of Acute Gastroenteritis
PHASE3
Active, not recruiting
27,776 participants
Started: Sep 24, 2024 · Completed: May 31, 2027
2 conditions
1 sponsor
283 locations
NCT06589713
Effect of Renal Impairment on Enpatoran Pharmacokinetics
PHASE1
Recruiting
40 participants
Started: Sep 24, 2024 · Completed: Apr 22, 2026
1 condition
2 sponsors
1 location
NCT06580275
The GLACE Study: Evaluating CLAAS With ICE Guided LAA Closure
NA
Recruiting
80 participants
Started: Sep 24, 2024 · Completed: Dec 31, 2025
2 conditions
1 sponsor
3 locations
NCT06700174
Lifetech AcuMark™ Sizing Balloon Post-Market Clinical Follow-up Study
N/A
Recruiting
100 participants
Started: Sep 24, 2024 · Completed: Mar 31, 2025
1 condition
1 sponsor
5 locations
NCT06881654
16% Carbamide Peroxide Home Bleaching: Soft vs. Rigid Tray in a Randomized Blinded Equivalence Trial
NA
Enrolling by invitation
100 participants
Started: Sep 24, 2024 · Completed: Dec 17, 2025
1 condition
1 sponsor
1 location
NCT06989099
Lymphedema Prevention Through Immediate Lymphatic Reconstruction (LILY) Trial.
PHASE2
Recruiting
50 participants
Started: Sep 24, 2024 · Completed: Aug 1, 2029
1 condition
1 sponsor
1 location
NCT06603558
Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine
N/A
Recruiting
3,000 participants
Started: Sep 24, 2024 · Completed: May 31, 2029
3 conditions
1 sponsor
4 locations
NCT06384079
Duration of Ureteral Rest Prior to Ureteral Reconstruction Surgery
N/A
Recruiting
25 participants
Started: Sep 24, 2024 · Completed: Nov 30, 2030
1 condition
1 sponsor
1 location
NCT06601023
Problem Management Plus Mindfulness-informed Legal Education for Addressing Gender-based Violence and Improving Parenting
NA
Not yet recruiting
24 participants
Started: Sep 24, 2024 · Completed: Jun 30, 2025
7 conditions
3 sponsors
0 locations
NCT06362824
Promoting Physical Activity in Older Hispanic/Latino(a) Adults
NA
Recruiting
130 participants
Started: Sep 24, 2024 · Completed: May 31, 2027
3 conditions
2 sponsors
2 locations
NCT06436742
A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS)
PHASE1
Active, not recruiting
16 participants
Started: Sep 24, 2024 · Completed: Nov 25, 2025
1 condition
1 sponsor
9 locations
NCT06474299
The Avenues Study: Dual Use Cessation
PHASE4
Recruiting
500 participants
Started: Sep 24, 2024 · Completed: Jul 31, 2028
2 conditions
2 sponsors
1 location
NCT06493279
Evaluate the Safety and Efficacy of Intrathecal Injection of RJK002 in Patients With Amyotrophic Lateral Sclerosis
PHASE1
Recruiting
9 participants
Started: Sep 24, 2024 · Completed: May 2, 2031
1 condition
2 sponsors
1 location
NCT06481891
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy
PHASE3
Recruiting
500 participants
Started: Sep 24, 2024 · Completed: Aug 31, 2026
2 conditions
1 sponsor
89 locations
NCT05687604
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
NA
Recruiting
1,500 participants
Started: Sep 24, 2024 · Completed: Jul 31, 2027
3 conditions
1 sponsor
1 location
NCT06233227
Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule
PHASE1
Not yet recruiting
28 participants
Started: Sep 24, 2024 · Completed: Dec 16, 2024
1 condition
1 sponsor
0 locations
NCT06724497
Evaluating the Accuracy of Soft Tissue Prediction in Patients With Mandibular Prognathism After Orthognathic Surgery Using Handheld Scanner Versus Optical Scanner A Prospective Clinical Trial
PHASE1/PHASE2
Enrolling by invitation
11 participants
Started: Sep 24, 2024 · Completed: Sep 24, 2025
2 conditions
1 sponsor
1 location
NCT06606847
A Study to Investigate the Effects of Durvalumab With Oleclumab Following Chemoradiation in Participants With Locally Advanced Unresectable Non-Small Cell Lung Cancer (LADOGA)
PHASE2
Active, not recruiting
30 participants
Started: Sep 24, 2024 · Completed: Jun 30, 2027
1 condition
1 sponsor
11 locations
NCT06601010
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Pancreatic Cancer.
N/A
Recruiting
30 participants
Started: Sep 24, 2024 · Completed: Aug 31, 2027
1 condition
1 sponsor
1 location
NCT06663007
RC48 Monotherapy or Combination With Envafolimab for CDK12 Alterations mCRPC With Standard Treatment Failure
PHASE1/PHASE2
Recruiting
72 participants
Started: Sep 24, 2024 · Completed: Aug 31, 2027
2 conditions
1 sponsor
1 location
NCT06733948
ChemoRT With and Without Dental Stent for Taste Protection in NPC Patients
PHASE2
Recruiting
50 participants
Started: Sep 24, 2024 · Completed: May 31, 2026
1 condition
2 sponsors
2 locations
NCT06581640
Chimeric Antigen Receptor Modified T Cells Targeting BCMA for the Treatment of Relapsed/Refractory Multiple Myeloma
PHASE2
Recruiting
5 participants
Started: Sep 24, 2024 · Completed: Dec 31, 2028
2 conditions
1 sponsor
1 location
NCT06391034
Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer
PHASE2
Recruiting
161 participants
Started: Sep 24, 2024 · Completed: Oct 31, 2032
1 condition
2 sponsors
1 location
NCT06614114
Albumin Bilirubin Index as a Predictor of Outcome of Variceal Bleeding
N/A
Recruiting
48 participants
Started: Sep 24, 2024 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT06664411
Pola-ZR2P in Previously Untreated DLBCL
PHASE2
Recruiting
80 participants
Started: Sep 24, 2024 · Completed: Dec 31, 2030
1 condition
1 sponsor
1 location
NCT06337422
Bioequivalence Study of Generic Celecoxib 200 mg Capsules
PHASE1
Not yet recruiting
40 participants
Started: Sep 23, 2024 · Completed: Oct 4, 2024
1 condition
1 sponsor
0 locations
NCT06323889
Longitudinal Monitoring During Intermittent Fasting Protocols in Obese Adults
NA
Recruiting
90 participants
Started: Sep 23, 2024 · Completed: Jan 31, 2027
3 conditions
1 sponsor
1 location
NCT06706856
Quantitative Ultrasound to Assess Steatotic Liver Disease in Children
N/A
Recruiting
120 participants
Started: Sep 23, 2024 · Completed: Jun 30, 2029
2 conditions
4 sponsors
1 location
NCT06484595
Clinical Trial Navigation to Increase Participation and Diversity in Cancer Clinical Trials
NA
Active, not recruiting
100 participants
Started: Sep 23, 2024 · Completed: Mar 31, 2026
2 conditions
3 sponsors
1 location
NCT06796972
In Utero Surgery for Fetal Myelomeningocele: Decision-making Mechanisms and Psychological Impact of Prenatal Therapy
NA
Recruiting
44 participants
Started: Sep 23, 2024 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT06638593
MIRRORS-FROZEN - Comparing Open Vs Robotic Surgery in the Management of Women with Complex Pelvic Adnexal Masses ≤ 8cm.
NA
Recruiting
40 participants
Started: Sep 23, 2024 · Completed: Feb 1, 2027
7 conditions
1 sponsor
1 location
NCT06275919
Regorafenib for Recurrent Grade 2 and 3 Meningioma (MIRAGE Trial)
PHASE2
Recruiting
104 participants
Started: Sep 23, 2024 · Completed: Mar 31, 2027
1 condition
2 sponsors
16 locations
NCT06690437
Observational Study for the Evaluation of the Clinical Performance and Safety Profile of the GALAXY FIXATION™ System and Orthofix Implantable Devices: GALAXY Study
N/A
Active, not recruiting
118 participants
Started: Sep 23, 2024 · Completed: Mar 31, 2025
3 conditions
1 sponsor
3 locations
NCT06439199
Biological, Prospective Study Evaluating the Dosage of Plasma Cytokines Including the FLT3 Ligand and IL6 of Patients Treated With Non-intensive Chemotherapy
N/A
Recruiting
60 participants
Started: Sep 23, 2024 · Completed: Dec 15, 2026
3 conditions
2 sponsors
1 location
NCT06559241
Remote Ischemic Conditioning for Acute Ischemic Stroke Treated with Mechanical Thrombectomy(RECAST-MT)
PHASE3
Recruiting
2,105 participants
Started: Sep 23, 2024 · Completed: Feb 28, 2027
2 conditions
1 sponsor
33 locations
NCT06004232
Prenatal Yoga to Prevent Postpartum Depression
NA
Recruiting
62 participants
Started: Sep 23, 2024 · Completed: Mar 31, 2026
1 condition
3 sponsors
1 location
NCT06959342
Modification of Inhibitory Control and Craving Through Transcranial Direct Current Stimulation (tDCS) as an Add-On Treatment for Substance Use Disorder
NA
Recruiting
162 participants
Started: Sep 23, 2024 · Completed: Sep 30, 2027
2 conditions
2 sponsors
2 locations
NCT06550596
Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot Ulcers
NA
Recruiting
100 participants
Started: Sep 23, 2024 · Completed: Oct 31, 2025
4 conditions
2 sponsors
1 location
NCT06570772
Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyvio
PHASE3
Recruiting
748 participants
Started: Sep 23, 2024 · Completed: Aug 31, 2026
1 condition
1 sponsor
100 locations
NCT06597331
Cardiac Assessment and Takotsubo-stunning Among COPD-exacerbations In-Hospital
N/A
Recruiting
200 participants
Started: Sep 23, 2024 · Completed: Sep 1, 2027
3 conditions
1 sponsor
1 location
NCT06574360
Dual Modulation of Sigma-1 and NMDA Receptors in the Treatment of Schizophrenia
PHASE2
Recruiting
90 participants
Started: Sep 23, 2024 · Completed: Mar 31, 2029
1 condition
1 sponsor
1 location
NCT06570902
Prospective WCD Post CABG Registry (CABG Registry)
N/A
Recruiting
910 participants
Started: Sep 23, 2024 · Completed: May 31, 2030
4 conditions
1 sponsor
4 locations
NCT06983509
Registry of Pre-mixed Solutions in Critically Ill Patients on the Continuous Renal Replacement Therapy
N/A
Recruiting
220 participants
Started: Sep 23, 2024 · Completed: Aug 31, 2025
1 condition
1 sponsor
10 locations
NCT06571513
Written Exposure Therapy to Improve Recovery Among Sexual Assault Survivors
NA
Recruiting
80 participants
Started: Sep 23, 2024 · Completed: Jul 31, 2026
1 condition
3 sponsors
1 location
Previous
1
More pages
798
799
800
801
802
803
804
More pages
2369
Next